All filters
Abstracts
Longitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020
M. Schütze Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
PK-virological algorithm to target risk of resistance among key populations in Togo
V. Ferré Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Association of APOBEC3 activity in HIV-1 DNA with non-B HIV-1 and low HIV-1 reservoir
B. Abdi Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Characterization of the newly proposed HIV-1 lineage within subtype A, sub-subtype A7
M. Lunar Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019
K. Serwin Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Epidemiology and transmission of drug resistance mutations among treatment-naïve people living with HIV-1 in Israel, 2010-2018
T. Wagner Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Assessment of HIV-1 DNA quantification methods in the Italian HIV DNA Network
I. Vicenti Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Nervous system pathology of HIV-positive people in the large industrial center within the Russian Federation: epidemiological analysis
V. Sotskova Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
AIDS mortality and lethality in Minsk, Belarus
M. Shylava Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Co-infections with hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern Romania
C. Sapaniuc Reviews in Antiviral Therapy & Infectious Diseases 2, 2021  
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Molecular Epidemiology Analysis Reveals Actively Growing Transmission Clusters in the Polyphyletic HIV-1 Infection in Cyprus (2019-2020)
C. Topcu Reviews in Antiviral Therapy & Infectious Diseases 2, 2021  
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Hepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from Ukraine
F. Malik Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Pharmacist-led telephone clinic is an effective strategy for treating patients with hepatitis C and removing barriers to attending appointments
A. Sommerville Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
A Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in Ukraine
Z. Islam Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
How Carbon Nanotubes can orchestrate the immunological response? Perspectives in vaccine application
E. Lima Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Frequency of IN gene region polymorphisms associated with ALLINIs effectiveness in HIV-1 subtype A6 dominating in Russia
I. Lapovok Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Pretreated drug-resistance in newly diagnosed HIV-1 patients in Portugal between 2014 and 2019
M. Pingarilho Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Application of the genetic diversity analysis for determination of HIV infection duration
A. Murzakova Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to Dolutegravir-based regimens in Africa
E. Ngoufack Jagni Semengue Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Comparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurement
R. Ehret Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Sensitivity of ultra-deep sequencing for dual HIV infection detection
D. Saleeva Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Molecular epidemiology of SARS-CoV-2 in Greece reveals low rates of onward virus transmission after lifting of travel restrictions based on risk assessment during summer 2020
E. Kostaki Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Characterization of the newly proposed HIV-1 lineage within subtype A, sub-subtype A7 - Maja Lunar
Presented at:
European Meeting on HIV & Hepatitis 2021
E-Posters
Association of APOBEC3 activity in HIV-1 DNA with non-B HIV-1 and low HIV-1 reservoir - Basma ABDI
Presented at:
European Meeting on HIV & Hepatitis 2021